Compare CCU & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCU | ENOV |
|---|---|---|
| Founded | 1850 | 1995 |
| Country | Chile | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Fluid Controls |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.4B |
| IPO Year | 2001 | 2008 |
| Metric | CCU | ENOV |
|---|---|---|
| Price | $11.74 | $23.29 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $12.00 | ★ $48.75 |
| AVG Volume (30 Days) | 223.8K | ★ 1.0M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | ★ 2.04% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.69 | $6.49 |
| Revenue Next Year | $6.15 | $5.56 |
| P/E Ratio | $18.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.35 | $21.00 |
| 52 Week High | $15.75 | $40.70 |
| Indicator | CCU | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 30.19 | 46.94 |
| Support Level | $11.62 | $21.30 |
| Resistance Level | $12.46 | $23.57 |
| Average True Range (ATR) | 0.40 | 1.40 |
| MACD | -0.12 | -0.10 |
| Stochastic Oscillator | 11.70 | 32.38 |
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.